UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A new experimental setup to characterize the dynamic mechanical behaviour of ballistic yarns

Measurement science & technology, 2016-10, Vol.27 (10), p.105902

2016

Volltextzugriff (PDF)

Development of a new method to determine dynamic tensile strength of ballistic yarns

EPJ Web of conferences, 2012, Vol.26, p.1053

2012

Volltextzugriff (PDF)

A new constitutive model for nitrogen austenitic stainless steel

Journal de Physique IV (Proceedings), 2003, Vol.110, p.9-14

2003

Volltextzugriff (PDF)

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Leukemia, 2013-04, Vol.27 (4), p.836-842

2013

Volltextzugriff (PDF)

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

The lancet oncology, 2012-04, Vol.13 (4), p.403-411

2012

Volltextzugriff (PDF)

Correction: Determination of the absorption function of laser‑heated soot particles from spectrally resolved laser‑induced incandescence signals using multiple excitation wavelengths

Applied physics. B, Lasers and optics, 2024, Vol.130 (1), Article 20

2024

Volltextzugriff (PDF)

Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion

Haematologica (Roma), 2014-08, Vol.99 (8), p.1350-1355

2014

Volltextzugriff (PDF)

Determination of the absorption function of laser-heated soot particles from spectrally resolved laser-induced incandescence signals using multiple excitation wavelengths

Applied physics. B, Lasers and optics, 2023-09, Vol.129 (9), Article 147

2023

Volltextzugriff (PDF)

Is acute myeloid leukemia a liquid tumor?

International journal of cancer, 2013-08, Vol.133 (3), p.534-543

2013

Volltextzugriff (PDF)

Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies

Haematologica (Roma), 2013-02, Vol.98 (2), p.217-221

2013

Volltextzugriff (PDF)

Descriptive analyses of maternally-derived antibody levels against porcine circovirus 2 (PCV-2) in 3- and 21-day-old piglets from farms of four European countries using different vaccination protocols in sows

Porcine Health Management., 2022-10, Vol.8 (1), p.1-41, Article 41

2022

Volltextzugriff (PDF)

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Leukemia, 2014-04, Vol.28 (4), p.973-975

2014

Volltextzugriff (PDF)

Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies

Antimicrobial Agents and Chemotherapy, 2006-01, Vol.50 (1), p.143-147

2006

Volltextzugriff (PDF)

Helicobacter spp. in Experimental Models of Colitis

Oral Mucosal Immunity and Microbiome, p.97-105

Volltextzugriff (PDF)

Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia

Haematologica (Roma), 2012-08, Vol.97 (8), p.1242-1245

2012

Volltextzugriff (PDF)

Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia

Cancer, 2011-09, Vol.117 (17), p.3999-4008

2011

Volltextzugriff (PDF)

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Haematologica (Roma), 2015-07, Vol.100 (7), p.927-934

2015

Volltextzugriff (PDF)

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

Leukemia, 2013-10, Vol.27 (10), p.2081-2083

2013

Volltextzugriff (PDF)

V-FAST: A Phase 1b Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Patients with Previously Untreated Acute Myeloid Leukemia

Blood, 2020-11, Vol.136 (Supplement 1), p.26-28

2020

Volltextzugriff (PDF)

Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial

Blood, 2021-11, Vol.138 (Supplement 1), p.1268-1268

2021

Volltextzugriff (PDF)

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

Blood, 2008-06, Vol.111 (11), p.5291-5297

2008

Volltextzugriff (PDF)

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma

Clinical cancer research, 2004-01, Vol.10 (1), p.88-95

2004

Volltextzugriff (PDF)

Preliminary results of V-FAST, a phase 1b master trial to investigate CPX-351 combined with targeted agents in newly diagnosed AML

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7026-7026

2021

Volltextzugriff (PDF)

V-FAST Master Trial: Subgroup Analysis of Outcomes with CPX-351 Plus Midostaurin in Adults with Newly Diagnosed Acute Myeloid Leukemia By FLT3 Mutation Type

Blood, 2022-11, Vol.140 (Supplement 1), p.3312-3314

2022

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(62)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Humans
(26)
Aged
(24)
Middle Aged
(23)
Adult
(20)
Female
(20)
Male
(20)
Oncology
(16)
Biological And Medical Sciences
(14)
Hematology
(14)
Medical Sciences
(14)
Aged, 80 And Over
(13)
Hematologic And Hematopoietic Diseases
(10)
Leukemia
(10)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(10)
Treatment Outcome
(10)
Prognosis
(9)
Adolescent
(7)
Leukemia, Myeloid, Acute - Drug Therapy
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new experimental setup to characterize the dynamic mechanical behaviour of ballistic yarns

Development of a new method to determine dynamic tensile strength of ballistic yarns

A new constitutive model for nitrogen austenitic stainless steel

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Correction: Determination of the absorption function of laser‑heated soot particles from spectrally resolved laser‑induced incandescence signals using multiple excitation wavelengths

Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion

Determination of the absorption function of laser-heated soot particles from spectrally resolved laser-induced incandescence signals using multiple excitation wavelengths

Is acute myeloid leukemia a liquid tumor?

Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies

Descriptive analyses of maternally-derived antibody levels against porcine circovirus 2 (PCV-2) in 3- and 21-day-old piglets from farms of four European countries using different vaccination protocols in sows

The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies

Helicobacter spp. in Experimental Models of Colitis

Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia

Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

V-FAST: A Phase 1b Master Trial to Investigate CPX-351 Combined with Various Targeted Agents in Patients with Previously Untreated Acute Myeloid Leukemia

Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma

Preliminary results of V-FAST, a phase 1b master trial to investigate CPX-351 combined with targeted agents in newly diagnosed AML

V-FAST Master Trial: Subgroup Analysis of Outcomes with CPX-351 Plus Midostaurin in Adults with Newly Diagnosed Acute Myeloid Leukemia By FLT3 Mutation Type

Suchergebnisse filtern